Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal bupivacaine vs magnesium sulfate vs saline after colon cancer surgery
IRCT20260214068852N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in colon adenocarcinoma comparing Intraperitoneal bupivacaine, Intraperitoneal magnesium sulfate and Normal saline placebo (3 arms). Primary endpoints: Postoperative surgical site pain, Nighttime sleep quality and 3 more. Started Jun 2026; status: completed.
02
Drugs
bupivacainemagnesium sulfate
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on IRCT20260214068852N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260214068852N1.